What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained

benzinga.com/news/fda/25/06/45776518/whats-behind-cellectar-biosciences-stock-surge-fda-update-explained

Cellectar Biosciences, Inc. (NASDAQ:CLRB) stock is trading higher on Wednesday.
As per data from Benzinga Pro, session volume stands at 361.96 million versus an average volume of 968.03k.
What Happened: The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation…

This story appeared on benzinga.com, 2025-06-04 16:35:08.
The Entire Business World on a Single Page. Free to Use →